Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Nashville | 10,824 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,824 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4841-4860 of 10,824 trials

Active not recruitingA Real-World Study to Gain Clinical Insights Into Roche Ophthalmology ProductsThe VOYAGER study is a primary data collection, non-interventional, prospective, multinational, multicenter study.NCT05476926·Phoenix, Arizona and 298 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedNeuroform Atlas Stent System StudyThe primary objective of this study is to demonstrate effectiveness and safety of the Neuroform Atlas Stent System for use with bare metal embolic coils.NCT02340585·Los Angeles, California and 24 others

TerminatedLong-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate CancerThis is a long-term prospective registry study to determine whether Prolaris testing in patients with favorable intermediate risk prostate cancer influences physician management…NCT03290508·Homewood, Alabama and 33 others

UnknownChemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00408408·Little Rock, Arkansas and 441 others

CompletedAldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well aldesleukin with or without ziv-aflibercept works in treating patients with stage III-IV melanoma that cannot be removed by surgery.NCT01258855·Duarte, California and 20 others

CompletedA Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)This is an observational study designed to follow patients with RA who have had an inadequate response to one or more anti-TNF therapies and who will receive Rituxan.NCT00443443·Birmingham, Alabama and 192 others

CompletedAcetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance RecoveryProspective multi-center phase 2b randomized placebo-controlled double-blinded interventional platform trial of two different pharmacologic therapies (intravenous Vitamin C or…NCT04291508·Birmingham, Alabama and 40 others

Active not recruitingA Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADThe goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85.NCT06709014·Chandler, Arizona and 77 others

TerminatedA Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaThe primary purpose of this study was to see how tasisulam-sodium affected metastatic melanoma when compared against paclitaxel as measured by overall survival.NCT01006252·Birmingham, Alabama and 121 others

CompletedA Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and GliomasThis is a Phase 1 dose-escalation study of PRT811, a protein arginine N-methyltransferase (PRMT) 5 inhibitor, in subjects with advanced cancers and high-grade gliomas who have…NCT04089449·Denver, Colorado and 10 others

CompletedDose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerThis is an open-label Phase 1b dose-escalation study to assess the safety, tolerability, and PK of OMP-54F28 when combined with nab-paclitaxel and gemcitabine.NCT02050178·Los Angeles, California and 4 others

CompletedDexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaThis randomized phase III trial is studying dexamethasone to see how well it works compared to prednisone during induction therapy.NCT00075725·Birmingham, Alabama and 233 others

CompletedEfficacy and Mechanisms of GLN Dipeptide in the SICURelative glutamine (GLN) deficiency may contribute to morbidity and mortality in surgical intensive care unit (SICU) patients.NCT00248638·Denver, Colorado and 4 others

CompletedA Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid TumoursThe main objective of the dose-escalation part of the trial is to determine the safety and tolerability, and to determine the Maximum Tolerated Dose and/or the Recommended Phase 2…NCT02952248·Sarasota, Florida and 12 others

TerminatedDescartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction TherapyTo assess Minimal Residual Disease (MRD)-negative Complete Response (sCR) rate after consolidation treatment with Descartes-08 in patients with high-risk myeloma who have residual…NCT04816526·Orange, California and 1 other

RecruitingSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Substudy 03C is part of a larger research study that is testing experimental treatments for renal cell carcinoma (RCC). The larger study is the umbrella study (U03).NCT07049926·San Francisco, California and 31 others

CompletedDS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before.NCT03523585·Chandler, Arizona and 226 others

CompletedA Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.This study will evaluate the efficacy, safety, pharmacokinetics, and patient-reported outcomes (PROs) of autogene cevumeran (RO7198457) plus pembrolizumab compared with…NCT03815058·Duarte, California and 40 others

CompletedA Retrospective Study of the iTotal CR Knee Replacement SystemThis study involves retrospective collection of data regarding the first approximately 100 iTotal Knee Replacement System surgeries and their short term outcomes at a small set of…NCT01564654·La Quinta, California and 3 others

CompletedStudy of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular DegenerationThis is a Phase II multicenter, dose-ranging, randomized, active treatment (monthly ITV injection)-controlled study to evaluate the efficacy, safety, and pharmacokinetics of…NCT02510794·Mesa, Arizona and 49 others

PreviousPage 243 of 542Next

Diabetes

in Nashville

Heart Diseasein Nashville